Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions. In addition, the company is involved in development and drug product manufacturing; provision of pharmaceutical analysis and testing services; medical research and development; manufacturing, sale, and development of medicine raw materials and relevant products; sale of drug products; pharmaceuticals and chemical manufacturing; wholesaling and retailing of drugs; sale, import and export trade; information technology; technology development; and research and experimental development activities. The company was founded in 1998 and is headquartered in Tianjin, China.
तुलना करने के लिए मीट्रिक्स | 002821 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध002821पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 28.9x | 19.8x | −0.5x | |
PEG अनुपात | −0.62 | 0.06 | 0.00 | |
क़ीमत/बुक | 1.7x | 2.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 4.8x | 2.9x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | 2.9% | 24.8% | 51.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 11.5% | 9.5% | अनलॉक करें |